Dr. Cynthia X. Qian shares an in-depth overview of Retinitis Pigmentosa, highlighting potential treatment approaches at various stages of disease progression. Dr. Qian further describes the first approved gene therapy for a specific type of Retinitis Pigmentosa and how this therapy sets the stage for targeted gene therapies for various inherited retinal dystrophies in the near future. About the Guest: Cynthia X. Qian is an assistant professor in the Department of Ophthalmology and the head of the electrophysiology laboratory, the inherited retinal diseases service, and the pediatric retina service at the University of Montreal. She is the current Vice President …

Cynthia X. Qian – Retinitis Pigmentosa: The arrival of gene therapy and what comes next. Read more »

Dr. Stephen McIntosh explains what dry eye is and how it can be recognized and treated, drawing on years of experience as an optometrist practising in diverse rural and urban settings. About the Guest: With international experience in eye care, cross-disciplinary research, and healthcare philanthropy, Dr. McIntosh brings a broad perspective to small-town eyecare, spending the past decade practicing optometry in small communities of rural Newfoundland.   His interests include disease prevention and health promotion through primary eye care, optics and the optical industry, as well as bioethics and health care philosophy.   His research background ranges from eco-toxicology and fish …

Dr. Stephen McIntosh – What is dry eye and what can patients do about it. Read more »

Greg Dubecky sheds light on raising a child with low vision, trying to understand retinitis pigmentosa research as a layperson and the need for knowledge transfer in ophthalmology.

Dr. Natalia Villa shares her experience working as a retinal surgeon in the United Kingdom during the first wave of COVID-19 and then in Canada during the second wave. Dr. Villa further shares stories of retinal implants that never made it to market, patents that may never make it to the clinic, the rise of technology in ophthalmology, and a high-security visit centered around John Lennon‘s glasses.

In this episode, Dr. Flavio Rezende explores the current state of affairs for retinal implants in Canada and worldwide, highlighting some of the benefits and limitations of the technology. Dr. Rezende further provides an overview of gene therapy for inherited retinal dystrophies, explaining why such treatments seem to advance slowly and how the recent pandemic and improved access to genetic testing may accelerate the development of additional sight-saving ocular gene therapies. About the Guest: Associate Professor at Department of Ophthalmology, University of Montreal Dr Rezende was the first surgeon to perform a retinal implant surgery in Quebec, Canada. His …

Flavio Rezende, MD, PhD. Retinal implants, ocular gene therapy, and the importance of genetic testing for inherited retinal dystrophies. Read more »

In this episode, Dr. Rubens Belfort talks about OncoPhone: A simple, free, easy-to-access service for regional ophthalmologists who require clinical advice about suspected ocular cancers. Dr. Belfort explains why he pioneered this initiative in the field of ocular oncology in Brazil, how the initiative has been received, how it has helped ophthalmologists and patients, and how others can do the same for other rare ocular diseases How WhatsApp has improved patient care in ocular oncology Pushing the envelope to provide better patient care Adapting to telemedicine The need for rapid consultation in ocular oncology and beyond About the Guest: …

Rubens Belfort, MD, PhD. A simple tech solution to a faster diagnosis in ocular oncology. Read more »